189 related articles for article (PubMed ID: 38363226)
1. Cytotoxic Programming of CD4+ T Cells Is Regulated by Opposing Actions of the Related Transcription Factors Eos and Aiolos.
Jones DM; Tuazon JA; Read KA; Leonard MR; Pokhrel S; Sreekumar BK; Warren RT; Yount JS; Collins PL; Oestreich KJ
J Immunol; 2024 Apr; 212(7):1129-1141. PubMed ID: 38363226
[TBL] [Abstract][Full Text] [Related]
2. Aiolos represses CD4
Read KA; Jones DM; Pokhrel S; Hales EDS; Varkey A; Tuazon JA; Eisele CD; Abdouni O; Saadey A; Leonard MR; Warren RT; Powell MD; Boss JM; Hemann EA; Yount JS; Xin G; Ghoneim HE; Lio CJ; Freud AG; Collins PL; Oestreich KJ
Nat Commun; 2023 Mar; 14(1):1652. PubMed ID: 36964178
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
Knudson CJ; Férez M; Alves-Peixoto P; Erkes DA; Melo-Silva CR; Tang L; Snyder CM; Sigal LJ
J Virol; 2021 Sep; 95(19):e0056621. PubMed ID: 34260270
[TBL] [Abstract][Full Text] [Related]
4. Integrated STAT3 and Ikaros Zinc Finger Transcription Factor Activities Regulate Bcl-6 Expression in CD4
Read KA; Powell MD; Baker CE; Sreekumar BK; Ringel-Scaia VM; Bachus H; Martin RE; Cooley ID; Allen IC; Ballesteros-Tato A; Oestreich KJ
J Immunol; 2017 Oct; 199(7):2377-2387. PubMed ID: 28848064
[TBL] [Abstract][Full Text] [Related]
5. Eos Promotes TH2 Differentiation by Interacting with and Propagating the Activity of STAT5.
Tuazon JA; Read KA; Sreekumar BK; Roettger JE; Yaeger MJ; Varikuti S; Pokhrel S; Jones DM; Warren RT; Powell MD; Rasheed MN; Duncan EG; Childs LM; Gowdy KM; Oestreich KJ
J Immunol; 2023 Aug; 211(3):365-376. PubMed ID: 37314436
[TBL] [Abstract][Full Text] [Related]
6. CD4
Hofland T; Danelli L; Cornish G; Donnarumma T; Hunt DM; de Carvalho LPS; Kassiotis G
Front Immunol; 2023; 14():1168125. PubMed ID: 37122720
[TBL] [Abstract][Full Text] [Related]
7. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.
Umeshappa CS; Nanjundappa RH; Xie Y; Freywald A; Xu Q; Xiang J
Immunology; 2013 Apr; 138(4):298-306. PubMed ID: 23113741
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of mousepox in H-2(d) mice: evidence for MHC class I-restricted CD8(+) and MHC class II-restricted CD4(+) CTL antiviral activity in the lymph nodes, spleen and skin, but not in the conjunctivae.
Cespedes IS; Toka FN; Schollenberger A; Gieryńska M; Niemiałtowski M
Microbes Infect; 2001 Nov; 3(13):1063-72. PubMed ID: 11709286
[TBL] [Abstract][Full Text] [Related]
9. CD4 CTL: living up to the challenge.
Cheroutre H; Husain MM
Semin Immunol; 2013 Nov; 25(4):273-81. PubMed ID: 24246226
[TBL] [Abstract][Full Text] [Related]
10. Ikaros Zinc Finger Transcription Factors: Regulators of Cytokine Signaling Pathways and CD4
Powell MD; Read KA; Sreekumar BK; Oestreich KJ
Front Immunol; 2019; 10():1299. PubMed ID: 31244845
[TBL] [Abstract][Full Text] [Related]
11. CD4 CTL, a Cytotoxic Subset of CD4
Takeuchi A; Saito T
Front Immunol; 2017; 8():194. PubMed ID: 28280496
[TBL] [Abstract][Full Text] [Related]
12. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage.
Takeuchi A; Badr Mel S; Miyauchi K; Ishihara C; Onishi R; Guo Z; Sasaki Y; Ike H; Takumi A; Tsuji NM; Murakami Y; Katakai T; Kubo M; Saito T
J Exp Med; 2016 Jan; 213(1):123-38. PubMed ID: 26694968
[TBL] [Abstract][Full Text] [Related]
13. Beta 2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes.
Taylor SF; Bender BS
Immunol Lett; 1995 May; 46(1-2):67-73. PubMed ID: 7590931
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs.
Sun J; Dodd H; Moser EK; Sharma R; Braciale TJ
Nat Immunol; 2011 Apr; 12(4):327-34. PubMed ID: 21297642
[TBL] [Abstract][Full Text] [Related]
15. CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination.
Sokke Umeshappa C; Hebbandi Nanjundappa R; Xie Y; Freywald A; Deng Y; Ma H; Xiang J
PLoS One; 2012; 7(10):e47004. PubMed ID: 23071696
[TBL] [Abstract][Full Text] [Related]
16. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
17. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
18. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T Lymphocyte Activation Signals Modulate Cytoskeletal Dynamics and Mechanical Force Generation.
Pathni A; Özçelikkale A; Rey-Suarez I; Li L; Davis S; Rogers N; Xiao Z; Upadhyaya A
Front Immunol; 2022; 13():779888. PubMed ID: 35371019
[TBL] [Abstract][Full Text] [Related]
20. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
